Cargando…
Effects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease
Coexisting Alzheimer’s disease (AD) pathology is common in Parkinson’s disease (PD). However, the implications of genetic risk scores (GRS) for AD have not been elucidated in PD. In 413 de novo PD and 195 healthy controls from the Parkinson’s Progression Marker Initiative database, the effects of GR...
Autores principales: | Lee, Young-gun, Jeong, Seong Ho, Park, Mincheol, Kang, Sung Woo, Baik, Kyoungwon, Jeon, Seun, Lee, Phil Hyu, Sohn, Young Ho, Ye, Byoung Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095668/ https://www.ncbi.nlm.nih.gov/pubmed/35545633 http://dx.doi.org/10.1038/s41531-022-00317-8 |
Ejemplares similares
-
Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021) -
Comparison Between (18)F-Florapronol and (18)F-Florbetaben Imaging in Patients With Cognitive Impairment
por: Baik, Kyoungwon, et al.
Publicado: (2023) -
Erratum
por: Lee, Young‐gun, et al.
Publicado: (2021) -
Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies
por: Kang, Sung Woo, et al.
Publicado: (2021) -
Neuropsychological Comparison of Patients With Alzheimer’s Disease and Dementia With Lewy Bodies
por: Kang, Sungwoo, et al.
Publicado: (2023)